Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
A cohort study at Peking University Third Hospital evaluating hereditary ovarian cancer risk prediction models and pathogenesis. It is curre…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: ASk Questions in GYnecologic Oncology (ASQ-GYO) [NA]
Clinical trial ASk Questions in Gynecologic Oncology (ASQ-GYO), sponsored by Ira Winer, is currently recruiting and covers ovarian and endom…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating ONC-201 in combination with weekly paclitaxel for platinum-refractory or resistant ovarian cancer; current…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers [NA]
This clinical trial update describes an ongoing study led by McGill University focused on early detection of endometrial and ovarian cancer …
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer [Phase 2]
Phase 2 trial RESOLVE is evaluating abemaciclib plus letrozole, with optional metformin, zotatifin, or gedatolisib, in endometrial cancer an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study of CDX-585 in Patients With Advanced Malignancies [Phase 1]
Phase 1 trial update showing completed enrollment and results for CDX-585 in patients with advanced solid tumors, including non-small cell l…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors [Phase 1, Phase 2]
TAK-853 is being studied in adults with folate receptor alpha–positive advanced ovarian cancer and other solid tumors in Phase 1/Phase 2 tri…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) [Phase 2]
A three-arm Phase II clinical trial evaluates dostarlimab alone or with bevacizumab versus nonplatinum chemotherapy in recurrent gynecologic…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting
A completed real-world observational study evaluating the safety and adverse events of olaparib in Chinese patients with ovarian cancer.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health [NA]
This clinical trial update from the University of Alabama at Birmingham describes a study evaluating multiple behavior interventions to impr…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome
This clinical trial update describes cascade genetic testing in families with newly diagnosed hereditary breast and ovarian cancer syndrome.…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Exercise Preconditioning in Ovarian Cancer [NA]
A clinical trial update for NCT05029154 investigating exercise preconditioning in ovarian cancer indicates the study has been terminated. Th…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This document reports the termination of a Phase 1/2 trial of AVB-S6-500 in combination with durvalumab for platinum-resistant or recurrent …
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer [Phase 2]
Phase 2 European trial evaluating enhanced DNA repair inhibition in ovarian cancer has completed enrollment and posted results. The study al…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer [NA]
This clinical trial update notes ongoing recruitment for a study of secondary interval cytoreductive surgery in platinum-sensitive recurrent…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial evaluating a biomarker-driven targeted therapy for recurrent platinum-resistant epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Assessment of Paclitaxel-Induced Neuropathy
This clinical trial update concerns assessment of paclitaxel-induced neuropathy in cancer patients, including breast and ovarian cancer, and…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: O-RADS MRI System on Early Detection of Ovarian Cancer
ClinicalTrials.gov update on the O-RADS MRI system for early detection of ovarian cancer; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Doxil/Caelyx BE Study [Phase 1]
Phase 1 bioequivalence study completion for Doxil/Caelyx in ovarian cancer, Kaposi sarcoma, multiple myeloma, and metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Interventions to Decrease Financial Toxicity [NA]
A completed clinical trial evaluating interventions to reduce financial toxicity in cancer care. The study was sponsored by the University o…
-
CLINICAL_TRIALS other · 2025-06-05Clinical Trial Update: Expanded Access of Vigil in Solid Tumors
The expanded access program for Vigil in solid tumors, including Ewing sarcoma, is temporarily not available.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study evaluating Hansoh's HS-10502 in adults with advanced solid tumors, including ovarian, breast, pancreatic, prostate, and colo…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies [Phase 1]
A Phase Ib safety study of Selinexor (KPT-330) in combination with standard chemotherapy or immunotherapy agents for patients with advanced …
-
CLINICAL_TRIALS withdrawal · 2025-06-03Clinical Trial Update: Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]
Withdrawal of a Phase 1/2 trial evaluating adding ASTX660 (tolinapant) to paclitaxel with or without bevacizumab in patients with recurrent …
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer [NA]
A Yale University trial is investigating exercise and lifestyle interventions for women with ovarian and endometrial cancer and is currently…